Drug Shortage Report for KENALOG-40 INJECTION

Last updated on 2023-01-31 History
Report ID 160669
Drug Identification Number 01999869
Brand name KENALOG-40 INJECTION 40MG/ML
Common or Proper name Triamcinolone Acetonide
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status MARKETED
Active Ingredient(s) TRIAMCINOLONE ACETONIDE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRA-ARTICULAR INTRAMUSCULAR INTRA-ARTICULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1ml
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-05-16
Actual start date 2022-05-16
Estimated end date 2023-01-27
Actual end date 2023-01-30
Shortage status Resolved
Updated date 2023-01-31
Company comments Demand increase for the drug.
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-01-31 English Compare
v10 2023-01-27 French Compare
v9 2023-01-27 English Compare
v8 2023-01-27 French Compare
v7 2023-01-27 English Compare
v6 2023-01-27 English Compare
v5 2022-06-03 French Compare
v4 2022-06-03 English Compare
v3 2022-05-17 English Compare
v2 2022-05-16 French Compare
v1 2022-05-16 English Compare

Showing 1 to 11 of 11